Additionally, we stated in the CY 2026 OPPS/ASC proposed rule that we believe that the pass-through payment category C1765 may also appropriately describe the Axoguard HA+ Nerve Protector TM because the device, as described by the applicant, is designed to be placed on and around neural structures to be a protective interface between a nerve and the surrounding tissue, to minimize the potential for soft tissue attachments, and to ensure the nerve's ability to glide through tissue structures during anatomic movement, and therefore may be appropriately described as an adhesion barrier consistent with devices described by C1765
Exclude oxygen by overlaying with nitrogen or argon if available, and minimize headspace in storage vials
It is being studied in diabetic neuropathy (NERVARA Phase 2 trial), sarcoidosis, and ischemic injury models
Depending on your needs, your provider may also recommend services such as Medical Weight Loss, Massage & Recovery, or Hormone Replacement Therapy to address multiple aspects of your health through a coordinated treatment plan
It reduces anxious thought patterns without sedation or dependency
A: IM injections deliver vitamins and nutrients to your body for maximum absorption by injecting deep into your muscles
